510(k) K261522

BioWave BioWraps by Biowave Corporation — Product Code GXY

K261522 is an FDA 510(k) premarket notification submitted by Biowave Corporation for the device "BioWave BioWraps". The FDA issued a decision of Substantially Equivalent on June 3, 2026. The device falls under product code GXY (Electrode, Cutaneous), a Class II device regulated under 21 CFR 882.1320. Biowave Corporation has at least 7 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 3, 2026
Date Received
May 7, 2026
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Electrode, Cutaneous
Device Class
Class II
Regulation Number
882.1320
Review Panel
NE
Submission Type